Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial*

OBJECTIVES: Occurrence of delirium in the ICU is associated with a longer stay in the ICU. To examine whether the use of ramelteon, a melatonin agonist, can prevent delirium and shorten the duration of ICU stay of critically ill patients. DESIGN: A single-center, triple-blinded, randomized placebo-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikimi, Mitsuaki, Numaguchi, Atsushi, Takahashi, Kunihiko, Miyagawa, Yasuhiro, Matsui, Kota, Higashi, Michiko, Makishi, Go, Matsui, Shigeyuki, Matsuda, Naoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012040/
https://www.ncbi.nlm.nih.gov/pubmed/29595562
http://dx.doi.org/10.1097/CCM.0000000000003132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012040/
https://www.ncbi.nlm.nih.gov/pubmed/29595562
http://dx.doi.org/10.1097/CCM.0000000000003132

Ejemplares similares